Literature DB >> 20595454

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

Janelle Yorke1, Jeffrey Swigris, Anne-Marie Russell, Shakeeb H Moosavi, Georges Ng Man Kwong, Mark Longshaw, Paul W Jones.   

Abstract

OBJECTIVE: In this study, we aimed to determine the validity and reliability of the Dyspnea-12 questionnaire (D-12) for the assessment of breathlessness in patients with interstitial lung disease (ILD).
METHODS: A total of 101 patients with ILD completed the D-12 (scale range, 0-36, with a high score indicating worse dyspnea), Medical Research Council (MRC) dyspnea scale, St. George Respiratory Questionnaire (SGRQ), and Hospital Anxiety and Depression Scale (HADS) at baseline, and 84 patients completed the D-12 and a global health transition score at follow-up 2 weeks later. D-12 psychometric properties, including floor and ceiling effects, internal consistency, test-retest reliability, and construct validity were examined.
RESULTS: The D-12 showed good internal consistency (Cronbach α, 0.93) and repeatability (intraclass correlation coefficient, 0.94). Its scores were significantly associated with MRC grade (r = 0.59; P < .001), SGRQ (symptoms, r = 0.57; activities, r = 0.78; impacts, r = 0.75; total, r = 0.79; P < .001). Factor analysis confirmed the previously determined structure of the D-12 in this patient group.
CONCLUSION: In patients with ILD, the D-12, a patient-reported measure of dyspnea severity that requires no reference to activity, is a reliable and valid instrument. It is short, simple to complete, and easy to score.

Entities:  

Mesh:

Year:  2010        PMID: 20595454      PMCID: PMC3035488          DOI: 10.1378/chest.10-0693

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

4.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

5.  Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  T Y Martinez; C A Pereira; M L dos Santos; R M Ciconelli; S M Guimarães; J A Martinez
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

Review 6.  Health-related quality of life among patients with idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Michael K Gould; Sandra R Wilson
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

7.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.

Authors:  D A Mahler; D H Weinberg; C K Wells; A R Feinstein
Journal:  Chest       Date:  1984-06       Impact factor: 9.410

8.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

9.  Normative data for the HADS from a large non-clinical sample.

Authors:  J R Crawford; J D Henry; C Crombie; E P Taylor
Journal:  Br J Clin Psychol       Date:  2001-11

10.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

View more
  36 in total

1.  Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Authors:  Janelle Yorke; Anne-Marie Russell; Jeff Swigris; Caroline Shuldham; Carol Haigh; Nikki Rochnia; Jennifer Hoyle; Paul W Jones
Journal:  J Asthma       Date:  2011-06-02       Impact factor: 2.515

2.  Reliability and validity of the multidimensional dyspnea profile.

Authors:  Paula M Meek; Robert Banzett; Mark B Parsall; Richard H Gracely; Richard M Schwartzstein; Robert Lansing
Journal:  Chest       Date:  2012-01-19       Impact factor: 9.410

3.  Getting serious about test-retest reliability: a critique of retest research and some recommendations.

Authors:  Denise F Polit
Journal:  Qual Life Res       Date:  2014-02-07       Impact factor: 4.147

4.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

Review 5.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

6.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

7.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

8.  Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding.

Authors:  Robert B Banzett; Shakeeb H Moosavi
Journal:  Eur Respir J       Date:  2017-03-02       Impact factor: 16.671

9.  Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.

Authors:  Mark B Parshall; Paula M Meek; David Sklar; Joe Alcock; Paula Bittner
Journal:  BMC Emerg Med       Date:  2012-05-24

Review 10.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.